2018 spring eb special preview

European Biotechnology Spring 2018

Bioprocessing & cGMP

SPECIAL

SPECIAL Special: Bioprocessing & cGMP Get on Board! › Publication date: 9 March, 2018

Hot topics in bioprocessing & GMP compliance Whether companies have own resources for biologics production or whether contract research organisations do the job: novel molecule formats, cell & gene therapies, more productive cell lines and continous manufacturing challenge their capabilities to innovate and differentiate from the rest of the pack. In the EU, the finalised ATMP guidelines, the new Annex 1 on Sterile Manufacturing, and the BREXIT also challenge the capabilities of producers to remain cGMP-compliant, particularly with emerging medicine formats such as CAR-T cell therapies. As novel formats for biologics and bio­similars emerge, diversification through special know-how is key to market success as well as it is in adapting to regulatory-driven innovations such as QbD or continous manufacturing.

Present your expertise CMOs & biologics producers, plant engineering experts, equipment and software specialists as well as QBD experts will have the opportunity to present their latest products, processes, and equipment in this special.

EuropBiotech Magazine goes out to decision makers throughout the entire European Life Sciences sector. Take advantage of to the journal’s highly relevant readership and grab this opportunity to target your audience!

Topics to be covered New products/processes, USP, DSP, single use/stainless steel equipment, media/cell line development, glycooptimisation, antibody conjugates, fill & finish, QbD, process development automation, DoE, GMP for cell/gene therapy, serialisation, cGMP risk analysis and documentation, digital tools, batch vs continous bioprocessing

Editorial Deadline 19-02-2018 Editorial Contact: Thomas Gabrielczyk Tel: +49-30-264921-50 Fax: +49-30-264921-11 t.gabrielczyk@biocom.de

Booking Deadline 19-02-2018

Publication Date 09-03-2018

Marketing Contact: Marketing Contact: Oliver Schnell Andreas Macht Tel: +49-30-264921-45 Tel: +49-30-264921-54 Fax: +49-30-264921-11 Fax: +49-30-264921-11 o.schnell@biocom.de a.macht@biocom.de

BIOCOM AG | Luetzowstr. 33–36 | D-10785 Berlin | www.biocom.de

Special: Bioprocessing & cGMP

Meet your audience!

European Biotechnology is published in co-operation with the following organisations: European Biotechnology NET WORK

Europe: european-biotechnology.net

Europe: medtecheurope.org

Europe: europabio.org

Europe: diahome.org

Switzerland: swissbiotech.org

Spain: asebio.com

Europe: medicinesforeurope.com

Ireland: ibec.ie/ibia

Denmark: danskbiotek.dk

The Netherlands: hollandbio.nl

Germany: biodeutschland.org

Portugal: www.p-bio.org

Austria: lifescienceaustria.at

France: france-biotech.org

Council of European BioRegions

CMYK

Italy: assobiotec.it

Sweden: swedenbio.com

Hungary: hungarianbiotech.org

Europe: cebr.net

Europe: ebe-biopharma.org

Norway: biotekforum.no

Finland: finbio.net

Belgium: bio.be

Blue: 100/15/0/35 Orange: 0/75/90/0

European Biotechnology covers the biotechnology sector of the current 28 EU member states, Norway and Switzerland. If you would like to subscribe, please refer to european-biotechnology.com

EBE

White Paper on Personalised Medicine